High Potency Pain Relief Cream
NDC Package 87773-001-01
Package Information
High Potency Pain Relief (capsaicin) cream is when using this product do not apply to wounds, broken or irritated skin Luse only as directed I avoid contact with eyes ora burning, stinging or warming sensation may occur upon application and generallymucous membraneslessens with continued use; if severe burning occurs, discontinue use do not bandage tightly do notuse with a heating pad or right after bathing /shower do not expose the treated area to heat or directsunlightdo not use at the same time as other topical analgesics. This formulation utilizes a cream delivery system. Marketed by Xiamen Weisiqi Technology Co., Ltd., this product is identified by NDC 87773-001 and is authorized under FDA application M017.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 87773 - Xiamen Weisiqi Technology Co., Ltd.
- 87773-001 - High Potency Pain Relief
- 87773-001-01 - 114 g in 1 BOTTLE
- 87773-001 - High Potency Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 87773-001-01 identifies a specific commercial package of 114 g in 1 bottle of High Potency Pain Relief, a human over the counter drug labeled by Xiamen Weisiqi Technology Co., Ltd.. This cream is formulated for topical use and contains capsaicin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Xiamen Weisiqi Technology Co., Ltd. on June 14, 2026. The current certification is valid through December 31, 2027.
How is this Xiamen Weisiqi Technology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 87773000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.